We are live on ! Find out more
VIA

Vident Investment Advisory Portfolio holdings

AUM $2.9B
1-Year Est. Return 24.67%
This Fund
S&P 500
This Quarter Est. Return
+7.71%
1 Year Est. Return
+24.67%
3 Year Est. Return
+82.63%
5 Year Est. Return
+113.33%
10 Year Est. Return
AUM
$3.08B
AUM Growth
+$429M
Cap. Flow
+$303M
Cap. Flow %
9.83%
Top 10 Hldgs %
12.86%
Holding
1,336
New
161
Increased
732
Reduced
335
Closed
102

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$47.7M
2
V icon
Visa
V
+$21.2M
3
CVX icon
Chevron
CVX
+$16.5M
4
PEP icon
PepsiCo
PEP
+$12.2M
5
ABT icon
Abbott
ABT
+$11.7M

Sector Composition

Rank Sector Weight
1 Technology 24.11%
2 Healthcare 14.19%
3 Consumer Discretionary 11.25%
4 Industrials 10.72%
5 Financials 10.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AAPL icon
1
Apple
AAPL
$4.97T
$84.2M 2.73%
510,401
+323,510
+173% +$47.7M
GOOGL icon
2
Alphabet (Google) Class A
GOOGL
$4.12T
$54.7M 1.77%
527,093
+91,165
+21% +$8.75M
CSCO icon
3
Cisco
CSCO
$443B
$39.3M 1.28%
752,735
-76,178
-9% -$3.72M
AVGO icon
4
Broadcom
AVGO
$1.76T
$38.1M 1.24%
594,420
-3,950
-0.7% -$238K
MSFT icon
5
Microsoft
MSFT
$2.9T
$37.1M 1.2%
128,666
+25,996
+25% +$6.63M
V icon
6
Visa
V
$701B
$35.4M 1.15%
156,919
+95,303
+155% +$21.2M
ADBE icon
7
Adobe
ADBE
$105B
$29.8M 0.97%
77,360
+7,162
+10% +$2.55M
ABBV icon
8
AbbVie
ABBV
$465B
$28.2M 0.92%
177,073
+30,837
+21% +$4.71M
LOW icon
9
Lowe's Companies
LOW
$121B
$24.8M 0.81%
124,235
+1,251
+1% +$254K
AMAT icon
10
Applied Materials
AMAT
$347B
$24.8M 0.8%
201,772
-4,187
-2% -$481K
MRK icon
11
Merck
MRK
$322B
$24.6M 0.8%
230,965
-6,155
-3% -$665K
XOM icon
12
ExxonMobil
XOM
$650B
$24.2M 0.79%
220,677
-3,032
-1% -$335K
JNJ icon
13
Johnson & Johnson
JNJ
$640B
$23.5M 0.76%
151,803
-48,415
-24% -$7.82M
CMCSA icon
14
Comcast
CMCSA
$87.3B
$23.3M 0.76%
614,740
+24,848
+4% +$940K
ABT icon
15
Abbott
ABT
$188B
$23M 0.75%
227,008
+110,597
+95% +$11.7M
HD icon
16
Home Depot
HD
$337B
$22.7M 0.74%
76,847
-13,506
-15% -$4.14M
UNH icon
17
UnitedHealth
UNH
$382B
$22.2M 0.72%
46,937
-3,566
-7% -$1.72M
LRCX icon
18
Lam Research
LRCX
$316B
$21.4M 0.7%
404,270
-3,810
-0.9% -$187K
CVX icon
19
Chevron
CVX
$382B
$20.3M 0.66%
124,303
+98,321
+378% +$16.5M
PFE icon
20
Pfizer
PFE
$143B
$19.4M 0.63%
474,922
-22,286
-4% -$963K
VRTX icon
21
Vertex Pharmaceuticals
VRTX
$123B
$18.1M 0.59%
57,577
+4,325
+8% +$1.3M
CVS icon
22
CVS Health
CVS
$135B
$17.4M 0.56%
234,165
+44,178
+23% +$3.7M
AZO icon
23
AutoZone
AZO
$51.3B
$17.4M 0.56%
7,068
+140
+2% +$341K
PEP icon
24
PepsiCo
PEP
$196B
$17.2M 0.56%
94,448
+69,717
+282% +$12.2M
AMGN icon
25
Amgen
AMGN
$209B
$17.2M 0.56%
71,097
-1,676
-2% -$411K

Similar funds

Vident Investment Advisory's Q1 2023 Portfolio in Review

As of Q1 2023, Vident Investment Advisory held 1,336 positions worth $3.08B, up 16% from $2.65B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Vident Investment Advisory deployed $303M of net new capital in Q1 2023, opening 161 new positions and adding to 732 existing holdings. Its largest new stake was Hormel Foods: 165,491 shares worth $6.6M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 21% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Philip Morris, an estimated $17.1M trimmed.

  • Vident Investment Advisory's largest Q1 2023 buy was Hormel Foods: 165,491 shares worth $6.6M.
  • Vident Investment Advisory added most to Apple in Q1 2023, an estimated $47.7M increase.
  • Vident Investment Advisory's biggest Q1 2023 reduction was Philip Morris, cutting an estimated $17.1M.
  • Vident Investment Advisory fully exited Coherent in Q1 2023, selling an estimated $5.89M.
  • Vident Investment Advisory's ten largest holdings make up 13% of its $3.08B portfolio in Q1 2023.
  • Vident Investment Advisory opened 161 new positions and closed 102 in Q1 2023.
  • Vident Investment Advisory's portfolio value rose 16% quarter-over-quarter to $3.08B.

Based on Vident Investment Advisory's 13F filing for Q1 2023, filed 15 May 2023.